Lipid-based Nutrient Supplements Do Not Affect Gut Bifidobacterium Microbiota in Malawian Infants: A Randomized Trial

J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):610-615. doi: 10.1097/MPG.0000000000001333.

Abstract

Objectives: The aim of the study was to assess the effect of nutritional supplementation with lipid-based nutrient supplements (LNS) and corn-soy blend flour on Bifidobacterium and Staphylococcus aureus gut microbiota composition in Malawian infants. In addition, the microbiota changes over time were characterized in the study infants.

Methods: Healthy 6-month-old Malawian infants were randomly assigned to 1 of 4 intervention schemes for a 6-month period. Infants in the control group were not provided with any supplementary food. Infants in other 3 groups received either micronutrient-fortified corn-soy blend, micronutrient-fortified LNS with milk protein base, or micronutrient-fortified LNS with soy protein base between 6 and 12 months of age. Fecal bifidobacteria and S aureus gut microbiota at 6 and 12 months of age were analyzed by quantitative real-time polymerase chain reaction method.

Results: There was no difference in change in bacterial prevalence or counts between the intervention groups during the 6-month study period. When looking at the total study population, higher counts of total bacteria (P = 0.028), Bifidobacterium genus (P = 0.027), B catenulatum (P = 0.031), and lower counts of B infantis (P < 0.001), B lactis (P < 0.001), B longum (P < 0.001), and S aureus (P < 0.001) were detected in the children's stools at 12 months rather than at 6 months of age.

Conclusions: The dietary supplementation did not have an effect on the Bifidobacterium and S aureus microbiota composition of the study infants. The fecal bifidobacterial diversity of the infants, however, changed toward a more adult-like microbiota profile within the observed time.

Trial registration: ClinicalTrials.gov NCT00524446.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Bifidobacterium* / isolation & purification
  • Dietary Fats*
  • Dietary Supplements*
  • Feces / microbiology
  • Female
  • Follow-Up Studies
  • Food, Fortified*
  • Gastrointestinal Microbiome*
  • Humans
  • Infant
  • Infant Food*
  • Malawi
  • Male
  • Micronutrients
  • Outcome Assessment, Health Care
  • Real-Time Polymerase Chain Reaction
  • Single-Blind Method
  • Staphylococcus aureus* / isolation & purification

Substances

  • Dietary Fats
  • Micronutrients

Associated data

  • ClinicalTrials.gov/NCT00524446